Variant report
Variant | esv20785 |
---|---|
Chromosome Location | chr12:30014747-30022341 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116415829 | chr12:30014747-30014748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190135609 | chr12:30014765-30014766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574664335 | chr12:30014773-30014774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542034899 | chr12:30014786-30014787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79786140 | chr12:30014787-30014788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192874193 | chr12:30014792-30014793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184968586 | chr12:30014830-30014831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189874674 | chr12:30014843-30014844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529640414 | chr12:30014854-30014855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs180675211 | chr12:30014919-30014920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564834812 | chr12:30014932-30014933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138594793 | chr12:30014952-30014953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114183227 | chr12:30014955-30014956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185154349 | chr12:30015074-30015075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12817638 | chr12:30015100-30015101 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs2200273 | chr12:30015118-30015119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs537978856 | chr12:30015133-30015134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141583455 | chr12:30015178-30015179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2200274 | chr12:30015190-30015191 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs189181095 | chr12:30015216-30015217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2220130 | chr12:30015289-30015290 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs533575374 | chr12:30015297-30015298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181989960 | chr12:30015333-30015334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567049699 | chr12:30015341-30015342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185778451 | chr12:30015352-30015353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191769293 | chr12:30015416-30015417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575441272 | chr12:30015437-30015438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540076391 | chr12:30015439-30015440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538789573 | chr12:30015459-30015460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558187621 | chr12:30015460-30015461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573154317 | chr12:30015461-30015462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183232065 | chr12:30015480-30015481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2200275 | chr12:30015494-30015495 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs186196253 | chr12:30015546-30015547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558489915 | chr12:30015547-30015548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146188550 | chr12:30015550-30015551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77583487 | chr12:30015622-30015623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs78249972 | chr12:30015686-30015687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs142722426 | chr12:30015704-30015705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191436673 | chr12:30015712-30015713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150588631 | chr12:30015752-30015753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527263720 | chr12:30015845-30015846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2220131 | chr12:30015887-30015888 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs567012361 | chr12:30015929-30015930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537505215 | chr12:30016022-30016023 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549467176 | chr12:30016064-30016065 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139592548 | chr12:30016082-30016083 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539657551 | chr12:30016103-30016104 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144423475 | chr12:30016148-30016149 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182166890 | chr12:30016149-30016150 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Osteosarcoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:30014400-30016800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr12:30016000-30017600 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
3 | chr12:30016200-30016800 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
4 | chr12:30016200-30017200 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
5 | chr12:30016400-30017200 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
6 | chr12:30016600-30016800 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
7 | chr12:30016800-30018200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
8 | chr12:30017000-30017200 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
9 | chr12:30017000-30017400 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
10 | chr12:30018200-30023600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
11 | chr12:30020200-30027000 | Weak transcription | Fetal Kidney | kidney |